Muhammad Naveed Uz ZAFAR

Dr. Muhammad Naveed Uz ZAFAR

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2025 in Journal of Carcinogenesis
Verified
Journal Article
Open access
PDF file
TKTania Khattak
Tania Khattak
AKAftab Ahmad Khan
Aftab Ahmad Khan
MWMaryam Waqar
Maryam Waqar
ASAmber Shami
Amber Shami
SHSara Habib
Sara Habib
TATahreem Arshad
Tahreem Arshad
Background: Uterine cancer, largely endometrial carcinoma, is among the most common gynecological malignancies worldwide, with incidence and mortality exhibiting marked geographical disparities. Recent trends highlight a rising incidence in both high-income countries (HICs) and low- and middle-income countries (LMICs), with obesity, elevated body mass index (BMI), and sociodemographic shifts identified as key risk factors. Histopathologically, endometrioid adenocarcinomas remain strongly associated with metabolic risk profiles, while aggressive non-endometrioid subtypes (such as uterine serous carcinoma, clear cell carcinoma, and carcinosarcoma) disproportionately drive mortality. Although human papillomavirus (HPV) vaccination primarily targets cervical carcinogenesis, emerging evidence suggests broader oncological and histopathological benefits in modifying gynecological cancer risk. Methods: A systematic review was conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, identifying 11 eligible studies from global databases and reference lists. Eligible studies included global burden analyses, regional cancer registry reports, risk factor evaluations, and narrative reviews addressing preventive strategies, including HPV vaccination. Results: Global evidence demonstrates a steadily increasing incidence of uterine cancer, particularly in HICs, while LMICs experience rising mortality due to delayed diagnosis and limited oncological treatment infrastructure. Obesity and high BMI were consistently identified as dominant modifiable risk factors across datasets. Age–period–cohort analyses revealed increasing incidence among younger cohorts. Two reviews emphasized HPV vaccination as an indirect but valuable preventive strategy in gynecologic oncology. Conclusion: The global burden of uterine cancer is rising, driven primarily by obesity and sociodemographic transitions, while health system inequities sustain high mortality in LMICs. Prevention strategies, including weight management, lifestyle modification, metabolic risk reduction, and HPV vaccination, should be integrated into comprehensive cancer control programs to mitigate future burden

9 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MNMuhammad Abdullah Naveed
Muhammad Abdullah Naveed
FAFaizan Ahmed
Faizan Ahmed
AAAhila Ali
Ahila Ali
BABazil Azeem
Bazil Azeem
MKMuhammad Kashan
Muhammad Kashan
RARaheel Ahmed
Raheel Ahmed
Backgrounds: Renal complications of diabetes mellitus pose a significant public health challenge, contributing to substantial morbidity and mortality globally. Understanding temporal trends and regional disparities in mortality related to diabetic nephropathy is crucial for guiding targeted interventions and policy decisions. Our study aimed to analyze the trends and regional differences in mortality related to renal complications of diabetes among adults in the United States from 1999 to 2020.Methods: A retrospective analysis has been conducted using death certificate data from the CDC WONDER database, spanning from 1999 to 2020, to investigate mortality related to renal complications of diabetes in adults aged 35 or above. Age-adjusted mortality rate (AAMR) per 100,000 persons and annual percent change (APC) were computed, with stratification by year, sex, race/ethnicity, and geographic regionResults: Between 1999 and 2020, a total of 525,804 deaths occurred among adults aged 35 to 85+ years due to renal-related issues associated with diabetes. The age-adjusted mortality rate (AAMR) for renal-related deaths in adult diabetic patients showed a consistent increase from 1.6 in 1999 to 34.9 in 2020 (AAPC: 17.23; 95% CI: 13.35-28.79). Throughout the study period, men consistently had higher AAMR than women (overall AAMR for men: 17.8, 95% CI: 17.7-17.9; for women: 11.2, 95% CI: 11.1-11.2). In 1999, the AAMR for men was 1.6, increasing to 27.6 by 2020, while for women, it was 1.8 in 1999 and rose to 44.2 by 2020 (Men: AAPC: 17.54, 95% CI: 13.09-29.53; Women: AAPC: 15.55, 95% CI: 13.35-21.10). American Indian/Alaska Native adults exhibited the highest overall AAMR (36.1), followed by Black/African American (25.5), Hispanic (22.5), Asian/Pacific Islander adults (15.4), and White Population (11.4). Significant variations in AAMR were observed among different states, with Oklahoma recording the highest (21.2) and Connecticut the lowest (7). Furthermore, AAMR varied by region (overall AAMR: Western 16.6; Midwestern: 14.4; Southern: 14.1; Northeastern: 9.9), and nonmetropolitan areas had a higher AAMR for renal complications of diabetes (16) compared to metropolitan areas (13.5).Conclusion: Our findings highlight a concerning rise in mortality related to renal complications of diabetes among U.S. adults over the past two decades, with notable disparities across demographic and geographic factors. These results underscore the urgent need for targeted interventions to mitigate the burden of diabetic nephropathy and reduce mortality rates in the United States.